CAS 842133-16-8

D-Glucitol, 1,5-anhydro-1-C-[4-methyl-3-[(5-phenyl-2-thienyl)methyl]phenyl]-, (1S)-

CAS: 842133-16-8

Formula: C₂₄H₂₆O₅S

Purity: 95%

Molecular weight: 426.5252

Ref: IN-DA00G3O8

(2R,3S,4R,5R,6S)-2-(Hydroxymethyl)-6-(4-methyl-3-((5-phenylthiophen-2-yl)methyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol

CAS: 842133-16-8

(2R,3S,4R,5R,6S)-2-(Hydroxymethyl)-6-(4-methyl-3-((5-phenylthiophen-2-yl)methyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol

Purity: 95%

Molecular weight: 426.53g/mol

Ref: 54-OR1073319

(2R,3S,4R,5R,6S)-2-(hydroxymethyl)-6-(4-methyl-3-((5-phenylthiophen-2-yl)methyl)phenyl)tetrahydro-2H-pyran-3,4,5-triol

CAS: 842133-16-8

Purity: 97%

Molecular weight: 426.5299987792969

Ref: 10-F789877

Canagliflozin Defluoro Impurity

CAS: 842133-16-8

Formula: C₂₄H₂₆O₅S

Molecular weight: 426.54

Ref: 4Z-C-152003

Canagliflozin Desfluoro Impurity

CAS: 842133-16-8

Formula: C₂₄H₂₆O₅S

Molecular weight: 426.53

Ref: ST-EA-CP-C7003

Defluoro-Canagliflozin

Controlled Product

CAS: 842133-16-8

Applications Defluoro-Canagliflozin is an impurity of Canagliflozin (C175190), a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Canagliflozin has been shown to dose dependently reduce calculated renal threshold for glucose excretion and increase urinary glucose excretion. Canagliflozin is a candidate for the treatment of type 2 diabetes and obesity.
References Chao, E. et al.: Drug Fut., 36, 351 (2011); Sha, S. et al.: Diab. Obes. Metab., 13, 669 (2011); Kipnes, M.S.: Clin. Invest., 1, 145 (2011);

Formula: C₂₄H₂₆O₅S

Color and Shape: Neat

Molecular weight: 426.525

Ref: TR-D228735